Magdalena Frydrychowicz

Dr. Magdalena Frydrychowicz

Poznan University of Medical Sciences, Poznań, Wielkopolskie, Poland
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2017 in Scandinavian Journal of Immunology
Verified
Journal Article
Closed access
PDF file
MFMagdalena Frydrychowicz
Magdalena Frydrychowicz
MBM. Boruczkowski
M. Boruczkowski
AKAgata Kolecka-Bednarczyk
Agata Kolecka-Bednarczyk
GDG. Dworacki
G. Dworacki

23 February 2023 in Journal of Applied Genetics
Verified
Journal Article
Open access
PDF file
MFMagdalena Frydrychowicz
Magdalena Frydrychowicz
LKLukasz Kuszel
Lukasz Kuszel
GDGrzegorz Dworacki
Grzegorz Dworacki
JBJoanna Budna
Joanna Budna
Lung cancer is the most common cause of cancer-related deaths in the world. One of the reasons of poor prognosis and high mortality of lung cancer patients is the diagnosis of the disease in its advanced stage. Despite innovative diagnostic methods and multiple completed and ongoing clinical trials aiming at therapy improvement, no significant increase in patients’ long-term survival has been noted over last decades. Patients would certainly benefit from early detection of lung cancer. Therefore, it is crucial to find new biomarkers that can help predict outcomes and tumor responses in order to maximize therapy effectiveness and avoid over- or under-treating patients with lung cancer. Nowadays, scientists’ attention is mainly dedicated to so-called liquid biopsy, which is fully non-invasive and easily available method based on simple blood draw. Among common liquid biopsy elements, circulating tumor nucleic acids are worth mentioning. Epigenetic biomarkers, particularly miRNA expression, have several distinct features that make them promising prognostic markers. In this review, we described miRNA’s involvement in tumorigenesis and present it as a predictor of cancer development and progression, potential indicator of treatment efficacy, and most importantly promising therapeutic target.

16 January 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
MPMarcin Przybylski
Marcin Przybylski
DPDominik Pruski
Dominik Pruski
Sonja Millert-KalińskaSonja Millert-Kalińska
Sonja Millert-Kalińska
MKMonika Krzyżaniak
Monika Krzyżaniak
MMMateusz de Mezer
Mateusz de Mezer
JŻJakub Żurawski
Jakub Żurawski
We aim to describe the relationship between the immunohistochemical expression patterns of HPV E4 markers and the presence of HPV major capsid protein (L1) in cervical tissues obtained by biopsy of patients with abnormal liquid-based cytology (LBC) results, HR HPV infections, or clinically suspicious cervix. A novel HPV-encoded marker, SILgrade-E4 (XR-E4-1), and an HPV (clone K1H8) antibody were used to demonstrate the expression in terminally differentiated epithelial cells with a productive HPV infection in the material. A semiquantitative analysis was performed based on light microscope images. The level of E4 protein decreased with the disease severity. Patients with LSIL-CIN 1 and HSIL-CIN 2 diagnoses had significantly lower levels of HPV major capsid protein (L1) than those without confirmed cervical lesions. Our analysis confirms a higher incidence of L1 in patients with molecularly diagnosed HPV infections and excluded lesions of LSIL-CIN 1 and HSIL-CIN 2. Further studies on the novel biomarkers might help assess the chances of the remission of lesions such as LSIL-CIN 1 and HSIL-CIN 2. Higher levels of E4 protein and L1 may confirm a greater probability of the remission of lesions and incidental infections. In the cytological verification or HPV-dependent screening model, testing for E4 protein and L1 expression may indicate a group with a lower risk of progression of histopathologically diagnosed lesions.

22 August 2024 in Cells
Verified
Journal Article
Open access
PDF file
MFMagdalena Frydrychowicz
Magdalena Frydrychowicz
MTMagdalena Telec
Magdalena Telec
JAJacek Anioła
Jacek Anioła
RKRadoslaw Kazmierski
Radoslaw Kazmierski
HCHanna Chowaniec
Hanna Chowaniec
MLMaria Lukasik
Maria Lukasik
The adaptive response occurs only after 7–10 days of antigen presentation. Nevertheless, the autoreactive T cells infiltrate the stroke lesion within the first 48 h. Thus, we hypothesized that the unconventional lymphocytes as invariant natural killer T cells (iNKT) and γδT cells that share immediate innate and delayed adaptive response features are involved in acute stroke pathophysiology. We assessed prospectively the quantity of circulating iNKT cells, γδT cells, and NK cells with flow cytometry in 52 subjects within three months after stroke, and we compared the results with those obtained in age-, sex-, and vascular risk factor-matched controls. We studied lymphocyte parameters regarding clinical outcomes, infarct volume, stroke-associated infection (SAI), and burden risk factors. The reduced number of circulating γδT cells and decreased percentage of the Vδ2 subset in the acute phase of stroke correlated with worse neurological status in the recovery phase. In subjects treated with thrombolysis and those who developed SAI, a lower percentage of γδT cells in the 90-day follow-up was observed. An increased percentage of iNKT cells in the acute and subacute phases of stroke was observed, and it was related to the worse clinical status. The circulating NK cells do not change temporarily or affect the outcomes after stroke. It seems that γδT cells play a long-lasting role in ischemic stroke, mainly related to the Vδ2 subset. The role of iNKT cells appears to be detrimental, especially in the acute and subacute phases of stroke. The effect of circulating NK cells on the outcome after stroke seems negligible.

28 March 2023 in Life
Verified
Journal Article
Open access
PDF file
AMAgnieszka Myszkowska-Torz
Agnieszka Myszkowska-Torz
MFMagdalena Frydrychowicz
Magdalena Frydrychowicz
MTMateusz Tomaszewski
Mateusz Tomaszewski
MFMagdalena Figlerowicz
Magdalena Figlerowicz
Anna ManiaAnna Mania
Anna Mania
Katarzyna Mazur-MelewskaKatarzyna Mazur-Melewska
Katarzyna Mazur-Melewska
Neuroborreliosis is a form of Lyme Borreliosis (LB) that affects various structures of the central and peripheral nervous system. Although most cases of LB can be cured with a course of antibiotics, some children can present prolonged symptoms, which may constitute post-treatment Lyme disease syndrome (PTLDS). The aim of our analysis was the long-term observation of children with NB and the determination of their risk of PTLDS. The clinical observation was supplemented by a laboratory study based on the assessment of the dynamics of anti-VlsE (variable major protein-like sequence, expressed) IgG antibodies in children with NB after antibiotic therapy. The prospective survey based on 40 children presented 1–2 forms of NB. The control group consisted of 36 patients with analogical symptoms for whom LB was excluded. Our long-term observation showed a low risk of developing long-term complications in children who received antibiotic therapy in accordance with the recommendations. The concentration of anti-VlsE IgG demonstrates a statistical significance for differences between the control and the study groups for each measurement period. Higher values of anti-VlsE IgG were observed in the study group, and the concentration decreased from the first measurement period to the next. The article emphasizes the importance of the long-term follow-up of children with neuroborreliosis.

5 April 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
LNLeszek Niepolski
Leszek Niepolski
ACAnna Czekała
Anna Czekała
MSMonika Seget-Dubaniewicz
Monika Seget-Dubaniewicz
MFMagdalena Frydrychowicz
Magdalena Frydrychowicz
PTPatrycja Talarska-Kulczyk
Patrycja Talarska-Kulczyk
JŻJakub Żurawski
Jakub Żurawski
Background: C3 glomerulopathies (C3GN) are a group of rare kidney diseases associated with impaired complement regulation. The effects of this disease include the accumulation of complement C3 in the kidneys. Based on the clinical data, as well as light, fluorescence, and electron microscopy results, the diagnoses were verified. The study group consisted of biopsy specimens, which were obtained from 332 patients who were diagnosed with C3 glomerulopathy. In all cases, histopathological examinations were performed; deposits of complement C3 and C1q components, as well as the immunoglobulins IgA, IgG, and IgM, were identified using immunofluorescence. Furthermore, electron microscopy was also performed. Results: The histopathological examination results presented cases of C3GN (n = 111) and dense deposit disease (DDD; n = 17). The non-classified (NC) group was the most numerous (n = 204). The lack of classification was due to the poor severity of the lesions, even on the electron microscopic examination or in the presence of intense sclerotic lesions. Conclusions: In cases of suspected C3 glomerulopathies, we believe an electron microscopy examination is necessary. This examination is beneficial in mild-to-extremely-severe cases of this glomerulopathy, where the lesions are barely discernible when using immunofluorescence microscopy.